Gossamer Bio, Inc. 4GB.MU Stock
Gossamer Bio, Inc. Price Chart
Gossamer Bio, Inc. 4GB.MU Financial and Trading Overview
Gossamer Bio, Inc. stock price | 0.9 EUR |
Previous Close | 1.09 EUR |
Open | 1.13 EUR |
Bid | 1.23 EUR x 0 |
Ask | 1.28 EUR x 0 |
Day's Range | 1.13 - 1.13 EUR |
52 Week Range | 0.87 - 14.7 EUR |
Volume | 360 EUR |
Avg. Volume | 0 EUR |
Market Cap | 114.37M EUR |
Beta (5Y Monthly) | 1.198755 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.79 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
4GB.MU Valuation Measures
Enterprise Value | 1.02B EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -4.861 |
Trading Information
Gossamer Bio, Inc. Stock Price History
Beta (5Y Monthly) | 1.198755 |
52-Week Change | -81.61% |
S&P500 52-Week Change | 20.43% |
52 Week High | 14.7 EUR |
52 Week Low | 0.87 EUR |
50-Day Moving Average | 1.13 EUR |
200-Day Moving Average | 5.29 EUR |
4GB.MU Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 95.44M |
Float | 79.18M |
Short Ratio | N/A |
% Held by Insiders | 4.74% |
% Held by Institutions | 118.76% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -51.53% |
Return on Equity (ttm) | -25925.77% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -210287008 EUR |
Net Income Avi to Common (ttm) | -220758000 EUR |
Diluted EPS (ttm) | -2.25 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 201.86M EUR |
Total Cash Per Share (mrq) | 2.12 EUR |
Total Debt (mrq) | 222.46M EUR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 5.186 |
Book Value Per Share (mrq) | -0.298 |
Cash Flow Statement
Operating Cash Flow (ttm) | -186538000 EUR |
Levered Free Cash Flow (ttm) | -101514128 EUR |
Profile of Gossamer Bio, Inc.
Country | Germany |
State | CA |
City | San Diego |
Address | 3013 Science Park Road |
ZIP | 92121 |
Phone | 858 684 1300 |
Website | https://www.gossamerbio.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 178 |
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
Q&A For Gossamer Bio, Inc. Stock
What is a current 4GB.MU stock price?
Gossamer Bio, Inc. 4GB.MU stock price today per share is 0.9 EUR.
How to purchase Gossamer Bio, Inc. stock?
You can buy 4GB.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gossamer Bio, Inc.?
The stock symbol or ticker of Gossamer Bio, Inc. is 4GB.MU.
Which industry does the Gossamer Bio, Inc. company belong to?
The Gossamer Bio, Inc. industry is Biotechnology.
How many shares does Gossamer Bio, Inc. have in circulation?
The max supply of Gossamer Bio, Inc. shares is 265.41M.
What is Gossamer Bio, Inc. Price to Earnings Ratio (PE Ratio)?
Gossamer Bio, Inc. PE Ratio is now.
What was Gossamer Bio, Inc. earnings per share over the trailing 12 months (TTM)?
Gossamer Bio, Inc. EPS is -0.79 EUR over the trailing 12 months.
Which sector does the Gossamer Bio, Inc. company belong to?
The Gossamer Bio, Inc. sector is Healthcare.